TOP STORIES
respiratory
Asthma

Cochrane backs fixed-dose combination inhaler for mild asthma


The Cochrane Airways Group has determined that use of a fixed dose inhaler containing both a steroid and beta₂‐agonist as required instead of short‐acting beta agonist (SABA) monotherapy as required is clinically effective in adults and adolescents with mild asthma. In...

The Cochrane Airways Group has determined that use of a fixed dose inhaler containing both a steroid and beta₂‐agonist as...

Read more